Intellectual Property India Publishes Patent Application for 'Compounds, Compositions And Methods Of Use To Treat Hypoparathyroidism And Osteoporosis' Filed by Septerna, Inc.

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517043571 A) filed by Septerna, Inc., San Francisco, on May 5, for 'compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis.'

Inventor(s) include Du, Xiaohui; Long, Daniel D.; Ewing, Todd J. A.; Bishop, Michael J.; Mckerrall, Steven J; Zhao, Liang; Larouche-Gauthier, Robin; Colwell, Curtis Eugene; Bouayad-Gervais, Samir; and Leblanc, Melissa.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "Disclosed are compounds that are parathyroid hormone receptor 1 agonists, and methods useful for preventing or treating osteoporosis, fracture, osteomalacia, arthritis, thrombocytopenia, hypoparathyroidism, hyperphosphatemia or tumoral calcinosis."

The patent application was internationally filed on Oct. 24, 2023, under International application No.PCT/US2023/035798.

Disclaimer: Curated by HT Syndication.